While the benefit of postoperative radiotherapy was shown in both HIF-1α-positive and negative cancers, more recurrences were recorded among patients with HIF-1α-positive primary tumours, this status also being associated with a higher risk of cancer-related deaths (HR = 1.9 [1.2–2.9], p = 0.004). This evidence concerns the gene HIF1A and cancer.